Merrimack Pharmaceuticals, Inc.
MACK
Stock Holding History
22NW LP
Seattle, Washington
$146M AUM
29.83%
1-Year Est. Return
Newtyn Management
New York
$936M AUM
27.23%
1-Year Est. Return
Western Standard LLC
Los Angeles, California
$190M AUM
40.88%
1-Year Est. Return
Nantahala Capital Management
New Canaan, Connecticut
$1.6B AUM
121.58%
1-Year Est. Return
Dimensional Fund Advisors
Austin, Texas
$481B AUM
30.42%
1-Year Est. Return
Vanguard Group
Malvern, Pennsylvania
$6.9T AUM
27.45%
1-Year Est. Return
BlackRock
New York
$5.7T AUM
30.48%
1-Year Est. Return
Sepio Capital
Salt Lake City, Utah
$1.84B AUM
18.57%
1-Year Est. Return
Wittenberg Investment Management
Carlisle, Massachusetts
$269M AUM
28.17%
1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver, British Columbia, Canada
$43.4B AUM
51.29%
1-Year Est. Return